
1.74 Delayed Data As of May 19 | ![]() Today’s Change | 1.49 Today|||52-Week Range 14.38 | -76.49% Year-to-Date |
Caribou Charges Ahead on Study Results May 17 / GuruFocus News - Paid Partner Content | Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Previous close | 1.78 |
Today’s open | 1.75 |
Day’s range | 1.68 - 1.81 |
Volume | 553,914 |
Average volume (3 months) | 671,417 |
Market cap | $98.9M |
Earnings growth (last year) | +75.11% |
Earnings growth (this year) | -242.73% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +375.72% |
P/E ratio | NM |
Price/Sales | 3.76 |
Price/Book | 1.06 |
---- | ||
VBLTVascular Biogenics L... | -0.02 | -1.27% |
SURFSurface Oncology Inc | -0.01 | -0.51% |
LPTXLeap Therapeutics In... | -0.01 | -0.82% |
Next reporting date | August 18, 2022 |
EPS forecast (this quarter) | -$0.44 |
Annual revenue (last year) | $115.5M |
Annual profit (last year) | -$30.6M |
Net profit margin | -26.49% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |